- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/0781 - B cellsProgenitors thereof
Patent holdings for IPC class C12N 5/0781
Total number of patents in this class: 693
10-year publication summary
|
34
|
39
|
65
|
77
|
57
|
58
|
71
|
58
|
57
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immusoft Corporation | 24 |
17 |
| Hoffmann-La Roche Inc. | 3369 |
14 |
| Duke University | 3056 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2548 |
13 |
| F. Hoffmann-La Roche AG | 7920 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6347 |
11 |
| The Invention Science Fund II, LLC | 91 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
10 |
| The Regents of the University of California | 19803 |
9 |
| Crystal Bioscience Inc. | 82 |
9 |
| Iovance Biotherapeutics, Inc. | 337 |
9 |
| Centre National de La Recherche Scientifique | 10311 |
8 |
| President and Fellows of Harvard College | 5942 |
8 |
| Kaneka Corporation | 4487 |
8 |
| STEMCELL Technologies Canada Inc. | 260 |
8 |
| Institute for Research in Biomedicine | 99 |
7 |
| Sanofi Pasteur VaxDesign Corporation | 38 |
7 |
| Sdf Biopharma Inc. | 10 |
7 |
| Kling Biotherapeutics B.V. | 24 |
7 |
| The Johns Hopkins University | 5637 |
6 |
| Other owners | 498 |